Olema Oncology: Funding, Investors & Team (Oct 2026)
Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. The company focuses on the discovery, development, and commercialization of targeted therapies for women's cancers. It leverages the knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development. Olema leverages their deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance with the goal of transforming the standard of care for pre- and post-menopausal women living with cancer by developing more convenient and effective therapies.
Olema Oncology has raised $570M across 3 funding rounds on record, the most recent an undisclosed round of $190M announced in Nov 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Olema Oncology Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Olema Oncology Funding Rounds
Olema Oncology raised $130M in an undisclosed round announced in Sep 2023.
1.3 years later, an undisclosed round of $250M was announced in Dec 2024.
11 months later, an undisclosed round of $190M was announced in Nov 2025.
Olema Oncology Founders and Leadership Team
No contact details are on record for this team yet.
Olema Oncology Funding Compared to Other Biotechnology Startups
Olema Oncology's latest round of $190M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Olema Oncology in Biotechnology and San Francisco
Companies Similar to Olema Oncology
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Olema Oncology Funding FAQs
What does Olema Oncology do?
Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. The company focuses on the discovery, development, and commercialization of targeted therapies for women's cancers. It leverages the knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development. Olema leverages their deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance with the goal of transforming the standard of care for pre- and post-menopausal women living with cancer by developing more convenient and effective therapies.
How much funding has Olema Oncology raised?
Olema Oncology has raised $570M across 3 rounds on record. The most recent is an undisclosed round of $190M announced in Nov 2025.
When did Olema Oncology last raise funding?
Olema Oncology's most recent funding round on record is an undisclosed round of $190M, announced in Nov 2025.
Who founded Olema Oncology?
FundedIQ lists Peter Kushner (Founder) at Olema Oncology.
Where is Olema Oncology headquartered?
Olema Oncology is based in San Francisco, California, United States.
How many employees does Olema Oncology have?
Olema Oncology is in the 51-100 employee band.
How does Olema Oncology's funding compare to other Biotechnology startups?
Olema Oncology's latest round of $190M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Olema Oncology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Olema Oncology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.